A visual guide to vaccines for the routine vaccination programme
Updated 20 January 2025
© Crown copyright 2025
This publication is licensed under the terms of the Open Government Licence v3.0 except where otherwise stated. To view this licence, visit nationalarchives.gov.uk/doc/open-government-licence/version/3 or write to the Information Policy Team, The National Archives, Kew, London TW9 4DU, or email: psi@nationalarchives.gov.uk.
Where we have identified any third party copyright information you will need to obtain permission from the copyright holders concerned.
This publication is available at https://www.gov.uk/government/publications/a-visual-guide-to-vaccines-poster/a-visual-guide-to-vaccines-for-the-routine-vaccination-programme
Infanrix hexa or Vaxelis
| Vaccine trade name, manufacturer, abbreviation | Diseases protected against | Age due |
|---|---|---|
| Infanrix hexa (GSK) or Vaxelis (Sanofi Pasteur) Hexavalent vaccine DTaP/IPV/Hib/HepB | Diphtheria, tetanus, pertussis (whooping cough), polio, Haemophilus influenzae type b (Hib) and hepatitis B | 8, 12 and 16 weeks |
Rotarix
| Vaccine trade name, manufacturer, abbreviation | Diseases protected against | Age due |
|---|---|---|
| Rotarix (GSK) Rotavirus (oral) | Rotavirus gastroenteritis | 8 weeks and 12 weeks |
Bexsero
| Vaccine trade name, manufacturer, abbreviation | Diseases protected against | Age due |
|---|---|---|
| Bexsero (GSK) MenB | Meningococcal group B | 8 weeks, 16 weeks and one year |
Prevenar 13
| Vaccine trade name, manufacturer, abbreviation | Diseases protected against | Age due |
|---|---|---|
| Prevenar 13 (Pfizer) PCV | Pneumococcal (13 serotypes) | 12 weeks and one year |
Menitorix
| Vaccine trade name, manufacturer, abbreviation | Diseases protected against | Age due |
|---|---|---|
| Menitorix (GSK) Hib/MenC | Haemophilus influenzae type b (Hib) and meningococcal group C | One year |
MMRvaxPro or Priorix
| Vaccine trade name, manufacturer, abbreviation | Diseases protected against | Age due |
|---|---|---|
| MMRvaxPro (MSD) or Priorix (GSK) MMR | Measles, mumps and rubella | One year and 3 years, 4 months |
Boostrix-IPV or REPEVAX
| Vaccine trade name, manufacturer, abbreviation | Diseases protected against | Age due |
|---|---|---|
| Boostrix-IPV (GSK) or REPEVAX (Sanofi) dTaP/IPV | Diphtheria, tetanus, pertussis and polio | 3 years, 4 months |
Gardasil 9
| Vaccine trade name, manufacturer, abbreviation | Diseases protected against | Age due |
|---|---|---|
| Gardasil 9 (MSD) HPV | Cancers and genital warts caused by specific human papillomavirus (HPV) types | Boys and girls aged 12 to 13 years (school Year 8) |
REVAXIS
| Vaccine trade name, manufacturer, abbreviation | Diseases protected against | Age due |
|---|---|---|
| REVAXIS (Sanofi Pasteur) Td/IPV | Tetanus, diphtheria and polio | 14 years (school Year 9) |
MenQuadfi
| Vaccine trade name, manufacturer, abbreviation | Diseases protected against | Age due |
|---|---|---|
| MenQuadfi (Sanofi) MenACWY | Meningococcal groups A, C, W and Y | 14 years (school Year 9) |
ADACEL
| Vaccine trade name, manufacturer, abbreviation | Diseases protected against | Age due |
|---|---|---|
| ADACEL (Sanofi) Tdap | Tetanus, diphtheria and pertussis (whooping cough) | Pregnant women from 16 weeks gestation |
Abrysvo
| Vaccine trade name, manufacturer, abbreviation | Diseases protected against | Age due |
|---|---|---|
| Abrysvo (Pfizer) RSV | Respiratory Syncytial Virus | Pregnant women from 28 weeks gestation 75 years (1) |
Pneumovax 23
| Vaccine trade name, manufacturer, abbreviation | Diseases protected against | Age due |
|---|---|---|
| Pneumovax 23 (MSD) PPV | Pneumococcal (23 serotypes) | 65 years (and certain at-risk groups) (2) |
Shingrix
| Vaccine trade name, manufacturer, abbreviation | Diseases protected against | Age due |
|---|---|---|
| Shingrix (GSK) Shingles | Shingles | 50+ if severely immunosuppressed (no upper age limit) 65 years or 70 years of age (3) (remain eligible until their 80th birthday) |
Full schedule
Read full details of the routine immunisation schedule.
References
1. RSV vaccination programme
2. The Green Book: Pneumococcal chapter 25
3. See Green Book shingles chapter 28a for details on eligible age groups including severely immunosuppressed individuals from age 50.